The company is a global pharmaceutical company that manufactures a therapy for leukemia.
For our client to qualify for reimbursement renewal, the client was requested by the reimbursement agency to provide real-world evidence regarding the use and effectiveness of the treatment for the Belgian population within three years.
Our team of project managers helped the client design a Phase IV study in Belgium to collect the required data. This study was fully managed by Modis Life Sciences experts in different fields, including scientific writing, project management, site management and monitoring, data management and statistics. In addition, we developed an electronic data collection platform.
Results / added value:
Thanks to our support, the company successfully collected the required data within three years and was able to renew the reimbursement of the treatment.